Yang, J., Choi, W., Kim, H., Choi, J., Yoo, C., Lee, D., Shim, J. H., Kim, K. M., Lim, Y., Lee, H. C. (2025). Risk of proteinuria with atezolizumab plus bevacizumab versus lenvatinib in first-line systemic treatment for hepatocellular carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.558